BJP Virtual Issues
The following virtual issues are available:
Reviews: Best of 2009: Virtual Issue
We have collated below 20 of the top review articles from 2009. All articles are available free.
Emerging strategies for exploiting cannabinoid receptor agonists as medicines
Roger G Pertwee
Glycogen synthase kinase 3: more than a namesake
Geetha Vani Rayasam, Vamshi Krishna Tulasi, Reena Sodhi, Joseph Alex Davis, Abhijit Ray
Molecular basis for amino acid sensing by family C G-protein-coupled receptors
P Wellendorph, H Bräuner-Osborne
Nuclear receptors as therapeutic targets in cholestatic liver diseases
Gernot Zollner, Michael Trauner
Neural KCNQ (Kv7) channels
David A Brown, Gayle M Passmore
Calcium-activated potassium channels and endothelial dysfunction: therapeutic options?
Michel Félétou
The endocannabinoid system as a target for the treatment of motor dysfunction
Javier Fernández-Ruiz
The role of histamine H4 receptor in immune and inflammatory disorders
E Zampeli, E Tiligada
Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics
Frederic Heitz, May Catherine Morris, Gilles Divita
Allosteric modulators of NR2B-containing NMDA receptors: molecular mechanisms and therapeutic potential
Laetitia Mony, James NC Kew, Martin J Gunthorpe, Pierre Paoletti
Chemical vectors for gene delivery: a current review on polymers, peptides and lipids containing histidine or imidazole as nucleic acids carriers
Patrick Midoux, Chantal Pichon, Jean-Jacques Yaouanc, Paul-Alain Jaffrès
Therapeutic antibodies: successes, limitations and hopes for the future
Patrick Chames, Marc Van Regenmortel, Etienne Weiss, Daniel Baty
Nanotechnologies and controlled release systems for the delivery of antisense oligonucleotides and small interfering RNA
Elias Fattal, Gillian Barratt
G protein-coupled receptor hetero-dimerization: contribution to pharmacology and function
Graeme Milligan
EPAC proteins transduce diverse cellular actions of cAMP
Gillian Borland, Brian O Smith, Stephen J Yarwood
FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system
Volker Brinkmann
Prostanoid receptor antagonists: development strategies and therapeutic applications
RL Jones, MA Giembycz, DF Woodward
Impact of OATP transporters on pharmacokinetics
A Kalliokoski, M Niemi
Regulation of RhoGEF proteins by G12/13-coupled receptors
Sandra Siehler
Protective mechanisms of activated protein C in severe inflammatory disorders
Arne P Neyrinck, Kathleen D Liu, James P Howard, Michael A Matthay
G-protein coupled receptors: Virtual Issue
This virtual issue brings together a collection of recent papers and reviews covering a range of G-protein coupled receptors, organised by receptor type. It also incorporates some of the papers published in a BJP themed issue on GPCR from last September. The themed issue presents a range of work across the GPCR field, illustrating the emerging depth of understanding of the molecular interactions within GPCR signalling, the range of physiological systems and therapeutic applications that are becoming engaged, and the value of translating knowledge gained at different levels of organisation into an understanding at the organismal level.
Receptor Type Sub-headings
5-HT Adenosine
Triggering neurotrophic factor actions through adenosine A2A receptor activation: implications for neuroprotection
Ana M Sebastião, Joaquim A Ribeiro
The A2A-adenosine receptor: a GPCR with unique features?
J Zezula, M Freissmuth
Adenosine receptors and asthma in humans
C N Wilson
α1-AR
The α1L-adrenoceptor is an alternative phenotype of the α1A-adrenoceptor
C P Nelson
The α1A-adrenoceptor gene is required for the α1L-adrenoceptor-mediated response in isolated preparations of the mouse prostate
K T Gray, J L Short, S Ventura
α2-AR Amino Acid Sensing Family
Molecular basis for amino acid sensing by family C G-protein-coupled receptors
P Wellendorph, H Bräuner-Osborne
Annexin-A1
Annexin-A1: a pivotal regulator of the innate and adaptive immune systems
F D'Acquisto, M Perretti, R J Flower
β-AR
The rush to adrenaline: drugs in sport acting on the β-adrenergic system
E Davis, R Loiacono, R J Summers
β1- and β2-Adrenoceptor polymorphisms and cardiovascular diseases
Kirsten Leineweber, Gerd Heusch
Deciphering the β-adrenergic response in human embryonic stem cell-derived-cardiac myocytes: closer to clinical use?
D Catalucci, M L Bang, G Condorelli
β1- and β2-adrenoceptor responses in cardiomyocytes derived from human embryonic stem cells: comparison with failing and non-failing adult human heart
M Brito-Martins, S E Harding, N N Ali
Atypical pharmacologies at β-adrenoceptors
R J Summers
Metabolic responses to BRL37344 and clenbuterol in soleus muscle and C2C12 cells via different atypical pharmacologies and β2-adrenoceptor mechanisms
R A Ngala, J O'Dowd, S J Wang, A Agarwal, C Stocker, M A Cawthorne, J R S Arch
Agonist efficacy and receptor desensitization: from partial truths to a fuller picture
Steven J Charlton
Agonist-specific patterns of β2-adrenoceptor responses in human airway cells during prolonged exposure
Caroline Düringer, Gunilla Grundström, Eylem Gürcan, Ian A Dainty, Mandy Lawson, Solange H Korn, Anders Jerre, Hanna Falk Håkansson, Elisabet Wieslander, Karin Fredriksson, Carl Magnus Sköld, Magnus Löfdahl, Claes-Göran Löfdahl, David J Nicholls, David S Silberstein
On the mechanism of the persistent action of salmeterol: what is the current position?
RA Coleman
Molecular mechanisms for the persistent bronchodilatory effect of the β2-adrenoceptor agonist salmeterol
A Szczuka, M Wennerberg, A Packeu, G Vauquelin
Stimulation of cardiac β-adrenoceptors targets connexin 43
Kerstin Boengler
The signal transduction cascade regulating the expression of the gap junction protein connexin43 by β-adrenoceptors
A Salameh, S Krautblatter, S Karl, K Blanke, D Rojas Gomez, S Dhein, D Pfeiffer, J Janousek
Cannabinoid
CB2 cannabinoid receptors: new vistas
K Mackie, R A Ross
CXCR2 and CXCR3
Analysis of the pharmacokinetic/pharmacodynamic relationship of a small molecule CXCR3 antagonist, NBI-74330, using a murine CXCR3 internalization assay
L A Jopling, G F Watt, S Fisher, H Birch, S Coggon, M I Christie
GPR119
GPR119, a novel G protein-coupled receptor target for the treatment of type 2 diabetes and obesity
H A Overton, M C T Fyfe, C Reynet
Histamine
Molecular and biochemical pharmacology of the histamine H4 receptor
Rob Leurs, Paul L Chazot, Fiona C Shenton, Herman D Lim, Iwan JP de Esch
Melatonin
Melatonin receptors, heterodimerization, signal transduction and binding sites: what's new?
R Jockers, P Maurice, J A Boutin, P Delagrange
Neuromedin U & S
Emerging pharmacology and physiology of neuromedin U and the structurally related peptide neuromedin S
JD Mitchell, JJ Maguire, AP Davenport
NPY
Neuropeptide Y Y2 receptor in health and disease
S L Parker, A Balasubramaniam
Opioid
Agonist-selective mechanisms of GPCR desensitization
E Kelly, C P Bailey, G Henderson
Shadows across μ-Star? Constitutively active μ-opioid receptors revisited
Mark Connor
Neutral antagonist activity of naltrexone and 6β-naltrexol in naïve and opioid-dependent C6 cells expressing a µ-opioid receptor
MF Divin, FA Bradbury, FI Carroll, JR Traynor
Role of protein kinase C in functional selectivity for desensitization at the µ-opioid receptor: from pharmacological curiosity to therapeutic potential
Susan L Ingram, John R Traynor
Involvement of PKCα and G-protein-coupled receptor kinase 2 in agonist-selective desensitization of µ-opioid receptors in mature brain neurons
CP Bailey, S Oldfield, J Llorente, CJ Caunt, AG Teschemacher, L Roberts, CA McArdle, FL Smith, WL Dewey, E Kelly, G Henderson
Prostanoid
Prostanoid receptor antagonists: development strategies and therapeutic applications
RL Jones, MA Giembycz, DF Woodward
Agonism
Agonist-selective mechanisms of GPCR desensitization
E Kelly, C P Bailey, G Henderson
Conformational changes in G-protein-coupled receptors—the quest for functionally selective conformations is open
C Hoffmann, A Zürn, M Bünemann, M J Lohse
Agonist binding, agonist affinity and agonist efficacy at G protein-coupled receptors
P G Strange
G protein-coupled receptor hetero-dimerization: contribution to pharmacology and function
Graeme Milligan
Agonism and allosterism: the pharmacology of the free fatty acid receptors FFA2 and FFA3
Graeme Milligan, Leigh A. Stoddart, Nicola J. Smith
Atypical pharmacologies at β-adrenoceptors
R J Summers
Metabolic responses to BRL37344 and clenbuterol in soleus muscle and C2C12 cells via different atypical pharmacologies and β2-adrenoceptor mechanisms
R A Ngala, J O'Dowd, S J Wang, A Agarwal, C Stocker, M A Cawthorne, J R S Arch
Agonist efficacy and receptor desensitization: from partial truths to a fuller picture
Steven J Charlton
Agonist-specific patterns of β2-adrenoceptor responses in human airway cells during prolonged exposure
Caroline Düringer, Gunilla Grundström, Eylem Gürcan, Ian A Dainty, Mandy Lawson, Solange H Korn, Anders Jerre, Hanna Falk Håkansson, Elisabet Wieslander, Karin Fredriksson, Carl Magnus Sköld, Magnus Löfdahl, Claes-Göran Löfdahl, David J Nicholls, David S Silberstein
On the mechanism of the persistent action of salmeterol: what is the current position?
RA Coleman
Molecular mechanisms for the persistent bronchodilatory effect of the β2-adrenoceptor agonist salmeterol
A Szczuka, M Wennerberg, A Packeu, G Vauquelin
Dimerisation
G protein-coupled receptor hetero-dimerization: contribution to pharmacology and function
Graeme Milligan
Agonism and allosterism: the pharmacology of the free fatty acid receptors FFA2 and FFA3
Graeme Milligan, Leigh A. Stoddart, Nicola J. Smith
G-protein-coupled receptor heteromers: function and ligand pharmacology
R Franco, V Casadó, A Cortés, J Mallol, F Ciruela, S Ferré, C Lluis, E I Canela
Melatonin receptors, heterodimerization, signal transduction and binding sites: what's new?
R Jockers, P Maurice, J A Boutin, P Delagrange
On the fitting of binding data when receptor dimerization is suspected
J Giraldo
Modelling the interdependence between the stoichiometry of receptor oligomerization and ligand binding for a coexisting dimer/tetramer receptor system
X Rovira, M Vivó, J Serra, D Roche, PG Strange, J Giraldo
Signalling
β-arrestins and heterotrimeric G-proteins: collaborators and competitors in signal transduction
K DeFea
G-protein-coupled receptor phosphorylation: where, when and by whom
A B Tobin
Kinetics of G-protein-coupled receptor signals in intact cells
M J Lohse, P Hein, C Hoffmann, V O Nikolaev, J-P Vilardaga, M Bünemann
Annexin-A1: a pivotal regulator of the innate and adaptive immune systems
F D'Acquisto, M Perretti, R J Flower
cAMP signal transduction in the heart: understanding spatial control for the development of novel therapeutic strategies
Manuela Zaccolo
EPAC proteins transduce diverse cellular actions of cAMP
Gillian Borland, Brian O Smith, Stephen J Yarwood
Role of G12 proteins in oncogenesis and metastasis
Juhi Juneja, Patrick J Casey
Regulation of RhoGEF proteins by G12/13-coupled receptors
Sandra Siehler
Role of protein kinase C in functional selectivity for desensitization at the µ-opioid receptor: from pharmacological curiosity to therapeutic potential
Susan L Ingram, John R Traynor
Involvement of PKCα and G-protein-coupled receptor kinase 2 in agonist-selective desensitization of µ-opioid receptors in mature brain neurons
CP Bailey, S Oldfield, J Llorente, CJ Caunt, AG Teschemacher, L Roberts, CA McArdle, FL Smith, WL Dewey, E Kelly, G Henderson
Pathology or Therapeutic Applications
Neuropeptide Y Y2 receptor in health and disease
S L Parker, A Balasubramaniam
GPR119, a novel G protein-coupled receptor target for the treatment of type 2 diabetes and obesity
H A Overton, M C T Fyfe, C Reynet
The rush to adrenaline: drugs in sport acting on the β-adrenergic system
E Davis, R Loiacono, R J Summers
Annexin-A1: a pivotal regulator of the innate and adaptive immune systems
F D'Acquisto, M Perretti, R J Flower
Adenosine receptors and asthma in humans
C N Wilson
β1- and β2-Adrenoceptor polymorphisms and cardiovascular diseases
Kirsten Leineweber, Gerd Heusch
Role of G12 proteins in oncogenesis and metastasis
Juhi Juneja, Patrick J Casey
Prostanoid receptor antagonists: development strategies and therapeutic applications
RL Jones, MA Giembycz, DF Woodward
Deciphering the β-adrenergic response in human embryonic stem cell-derived-cardiac myocytes: closer to clinical use?
D Catalucci, M L Bang, G Condorelli
β1- and β2-adrenoceptor responses in cardiomyocytes derived from human embryonic stem cells: comparison with failing and non-failing adult human heart
M Brito-Martins, S E Harding, N N Ali
The α1L-adrenoceptor is an alternative phenotype of the α1A-adrenoceptor
C P Nelson
The α1A-adrenoceptor gene is required for the α1L-adrenoceptor-mediated response in isolated preparations of the mouse prostate
K T Gray, J L Short, S Ventura
Cardiovascular
cAMP signal transduction in the heart: understanding spatial control for the development of novel therapeutic strategies
Manuela Zaccolo
Cancer
Role of G12 proteins in oncogenesis and metastasis
Juhi Juneja, Patrick J Casey
Neuro
Lung
Agonist efficacy and receptor desensitization: from partial truths to a fuller picture
Steven J Charlton
Agonist-specific patterns of β2-adrenoceptor responses in human airway cells during prolonged exposure
Caroline Düringer, Gunilla Grundström, Eylem Gürcan, Ian A Dainty, Mandy Lawson, Solange H Korn, Anders Jerre, Hanna Falk Håkansson, Elisabet Wieslander, Karin Fredriksson, Carl Magnus Sköld, Magnus Löfdahl, Claes-Göran Löfdahl, David J Nicholls, David S Silberstein
On the mechanism of the persistent action of salmeterol: what is the current position?
RA Coleman
Molecular mechanisms for the persistent bronchodilatory effect of the β2-adrenoceptor agonist salmeterol
A Szczuka, M Wennerberg, A Packeu, G Vauquelin
Receptor Theory
Orphan GPCR research
S Chung, T Funakoshi, O Civelli
On the fitting of binding data when receptor dimerization is suspected
J Giraldo
Modelling the interdependence between the stoichiometry of receptor oligomerization and ligand binding for a coexisting dimer/tetramer receptor system
X Rovira, M Vivó, J Serra, D Roche, PG Strange, J Giraldo
Shadows across μ-Star? Constitutively active μ-opioid receptors revisited
Mark Connor
Neutral antagonist activity of naltrexone and 6β-naltrexol in naïve and opioid-dependent C6 cells expressing a µ-opioid receptor
MF Divin, FA Bradbury, FI Carroll, JR Traynor
Cannabinoids: Virtual Issue
In recent years, BJP has been at the forefront of cannabinoid publications, producing two highly successful Themed Issues on cannabinoids. We are planning a future Themed Issue on cannabinoids for publication in early 2010. For more information visit www.brjpharmacol.org.
In a special virtual issue, we have collated cannabinoid papers published in BJP over the last 12 months (back from June 2009) – see below. To access all cannabinoid papers published in BJP click here. If accessing this link for the first time, please also select ‘Go’ to activate the search.
Interaction between cannabinoid CB1 receptors and endogenous ATP in the control of spontaneous mechanical activity in mouse ileum
S Baldassano, MG Zizzo, R Serio, F Mulè
Potential anxiolytic- and antidepressant-like effects of salvinorin A, the main active ingredient of Salvia divinorum, in rodents
Daniela Braida, Valeria Capurro, Alessia Zani, Tiziana Rubino, Daniela Viganò, Daniela Parolaro, Mariaelvina Sala
Peripheral and central sites of action for the non-selective cannabinoid agonist WIN 55,212-2 in a rat model of post-operative pain
CZ Zhu, JP Mikusa, Y Fan, PR Hollingsworth, M Pai, P Chandran, AV Daza, BB Yao, MJ Dart, MD Meyer, MW Decker, GC Hsieh, P Honore
Peripheral endocannabinoid dysregulation in obesity: relation to intestinal motility and energy processing induced by food deprivation and re-feeding
Angelo A Izzo, Fabiana Piscitelli, Raffaele Capasso, Gabriella Aviello, Barbara Romano, Francesca Borrelli, Stefania Petrosino, Vincenzo Di Marzo
Positive allosteric modulation of the human cannabinoid (CB1) receptor by RTI-371, a selective inhibitor of the dopamine transporter
Hernán A. Navarro, James L. Howard, Gerald T. Pollard, F. Ivy Carroll
The endocannabinoid system as a target for the treatment of motor dysfunction
Javier Fernández-Ruiz
Synthetic and plant-derived cannabinoid receptor antagonists show hypophagic properties in fasted and non-fasted mice
Gernot Riedel, Paola Fadda, Susan McKillop-Smith, Roger G Pertwee, Bettina Platt, Lianne Robinson
Inhibition of human recombinant T-type calcium channels by the endocannabinoid N-arachidonoyl dopamine
Hamish R Ross, Andrew J Gilmore, Mark Connor
Emerging strategies for exploiting cannabinoid receptor agonists as medicines
Roger G Pertwee
Acute hypertension reveals depressor and vasodilator effects of cannabinoids in conscious rats
W-S Vanessa Ho, Sheila M Gardiner
5-HT1A receptors are involved in the cannabidiol-induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats
Leonardo B.M. Resstel, Rodrigo F. Tavares, Sabrina F.S. Lisboa, Sâmia R.L. Joca, Fernando M.A. Corrêa, Francisco S. Guimarães
Effect of Δ9-tetrahydrocannabinol, a cannabinoid receptor agonist, on the triggering of transient lower oesophageal sphincter relaxations in dogs and humans
H Beaumont, J Jensen, A Carlsson, M Ruth, A Lehmann, GE Boeckxstaens
Inhibition of fatty acid amide hydrolase produces PPAR-α-mediated analgesia in a rat model of inflammatory pain
D R Sagar, D A Kendall, V Chapman
Virodhamine relaxes the human pulmonary artery through the endothelial cannabinoid receptor and indirectly through a COX product
H Kozłowska, M Baranowska, E Schlicker, M Kozłowski, J Laudañski, B Malinowska
MDA7: a novel selective agonist for CB2 receptors that prevents allodynia in rat neuropathic pain models
M Naguib, P Diaz, J J Xu, F Astruc-Diaz, S Craig, P Vivas-Mejia, D L Brown
Antinociceptive effects of tetrazole inhibitors of endocannabinoid inactivation: cannabinoid and non-cannabinoid receptor-mediated mechanisms
S Maione, E Morera, I Marabese, A Ligresti, L Luongo, G Ortar, V Di Marzo
Inhibitory effect of salvinorin A, from Salvia divinorum, on ileitis-induced hypermotility: cross-talk between κ-opioid and cannabinoid CB1 receptors
R Capasso, F Borrelli, M G Cascio, G Aviello, K Huben, J K Zjawiony, P Marini, B Romano, V Di Marzo, F Capasso, A A Izzo
Modulation of the anti-nociceptive effects of 2-arachidonoyl glycerol by peripherally administered FAAH and MGL inhibitors in a neuropathic pain model
J Desroches, J Guindon, C Lambert, P Beaulieu
Inhibitory activity of the novel CB2 receptor agonist, GW833972A, on guinea-pig and human sensory nerve function in the airways
M G Belvisi, H J Patel, V Freund-Michel, D J Hele, N Crispino, M A Birrell
Interactions between CB1 receptors and TRPV1 channels mediated by 12-HPETE are cytotoxic to mesencephalic dopaminergic neurons
S R Kim, E Bok, Y C Chung, E S Chung, B K Jin
Inhibition of fatty acid amide hydrolase by kaempferol and related naturally occurring flavonoids
L Thors, M Belghiti, C J Fowler
Differential modulation of AP-1- and CRE-driven transcription by cannabinoid agonists emphasizes functional selectivity at the CB1 receptor
B Bosier, E Hermans, D M Lambert
Cannabinoids reduce granuloma-associated angiogenesis in rats by controlling transcription and expression of mast cell protease-5
D De Filippis, A Russo, A D'Amico, G Esposito, P Concetta, M Cinelli, G Russo, T Iuvone
Cannabinoids reduce granuloma-associated angiogenesis in rats by controlling transcription and expression of mast cell protease-5
D De Filippis, A Russo, A D'Amico, G Esposito, C Pietropaolo, M Cinelli, G Russo, T Iuvone
Effects of Δ9-tetrahydrocannabivarin on [35S]GTPγS binding in mouse brain cerebellum and piriform cortex membranes
I Dennis, B J Whalley, G J Stephens
The cannabinoid receptor-1 antagonist rimonabant inhibits platelet activation and reduces pro-inflammatory chemokines and leukocytes in Zucker rats
A Schäfer, J Pfrang, J Neumüller, S Fiedler, G Ertl, J Bauersachs
Rimonabant in rats with a metabolic syndrome: good news after the depression
V Di Marzo, A Szallasi
The μ-opioid receptor agonist morphine, but not agonists at δ- or κ-opioid receptors, induces peripheral antinociception mediated by cannabinoid receptors
D da Fonseca Pacheco, A Klein, A de Castro Perez, C M da Fonseca Pacheco, J N de Francischi, I D G Duarte
Cannabidiol, extracted from Cannabis sativa, selectively inhibits inflammatory hypermotility in mice
R Capasso, F Borrelli, G Aviello, B Romano, C Scalisi, F Capasso, A A Izzo
_______________________________________
Free access to the two previous BJP cannabinoid Themed Issues – see below:
Cannabinoid Pharmacology (November 2007)
Endothelium: Virtual Issue
We have collected below, reviews and research papers on the topic of the Endothelium that BJP and our sister journal BJCP have published in the past year, and that should help researchers and students to find the latest work in this field.
Many of these papers come from an endothelium themed section published to commemorate the work of Robert Furchgott who discovered endothelium-derived relaxant factor and who died on 12th May 2009. Furchgott was awarded the Nobel Prize for this work, which has led to an array of new therapeutic targets.
An “Appreciation” of Robert Furchgott can be found here – written by William Martin.
The themed section starts with an editorial, and contains three reviews on the pathophysiology of the endothelium and the drug targets that this presents, four research papers and three commentaries on research. These are all also included in the list below.
Reviews
Endothelial Function
Endothelium-dependent contractions in SHR: a tale of prostanoid TP and IP receptors
Michel Félétou, Tony J Verbeuren, Paul M Vanhoutte
Endothelial Pathophysiology
Role of nitroso radicals as drug targets in circulatory shock
Emanuela Esposito, Salvatore Cuzzocrea
Calcium-activated potassium channels and endothelial dysfunction: therapeutic options?
Michel Félétou
Endothelial Ca2+-activated K+ channels in normal and impaired EDHF–dilator responses – relevance to cardiovascular pathologies and drug discovery
Ivica Grgic, Brajesh P Kaistha, Joachim Hoyer, Ralf Köhler
Endothelium-dependent contractions and endothelial dysfunction in human hypertension
Daniele Versari, Elena Daghini, Agostino Virdis, Lorenzo Ghiadoni, Stefano Taddei
Research Papers with Commentaries
EDHF
Evidence against C-type natriuretic peptide as an arterial 'EDHF'
C J Garland, K A Dora
C-type natriuretic peptide and endothelium-dependent hyperpolarization in the guinea-pig carotid artery
V Leuranguer, P M Vanhoutte, T Verbeuren, M Félétou
Endothelial Function
Defying the economists: a decrease in heart rate improves not only cardiac but also endothelial function
C R Triggle
Chronic heart rate reduction by ivabradine prevents endothelial dysfunction in dyslipidaemic mice
A Drouin, M-È Gendron, E Thorin, M-A Gillis, F Mahlberg-Gaudin, J-C Tardif
Signalling / Drug targets
Nitroxyl anion – the universal signalling partner of endogenously produced nitric oxide?
William Martin
A role for nitroxyl (HNO) as an endothelium-derived relaxing and hyperpolarizing factor in resistance arteries
Karen L Andrews, Jennifer C Irvine, Marianne Tare, Jacqueline Apostolopoulos, Joanne L Favaloro, Chris R Triggle, Barbara K Kemp-Harper
Vascular KATP channels: dephosphorylation and deactivation
Paolo Tammaro
Ca2+/calcineurin regulation of cloned vascular KATP channels: crosstalk with the protein kinase A pathway
NN Orie, AM Thomas, BA Perrino, A Tinker, LH Clapp
Understanding organic nitrates – a vein hope?
Mark R Miller, Roger M Wadsworth
Different effects of ascorbate deprivation and classical vascular nitrate tolerance on aldehyde dehydrogenase-catalysed bioactivation of nitroglycerin
MV Wenzl, G Wölkart, H Stessel, M Beretta, K Schmidt, B Mayer
Research Papers
EDHF
Hypertension and the absence of EDHF-mediated responses favour endothelium-dependent contractions in renal arteries of the rat
F S Michel, G S Man, R Y K Man, P M Vanhoutte
Flow-induced enhancement of vasoconstriction and blockade of endothelium-derived hyperpolarizing factor (EDHF) by ascorbate in the rat mesentery
A Stirrat, S Nelli, F J Dowell, W Martin
Endothelial function
Enhanced antithrombotic effects of unfractionated heparin in rats after repeated oral doses and its relationship to endothelial heparin concentration
L M Hiebert, T Ping, S M Wice
Assessment of endothelial function: comparison of the pulse wave response to β2-adrenoceptor stimulation with flow mediated dilatation
Curtis Rambaran, Benyu Jiang, James M. Ritter, Ajay Shah, Lalit Kalra, Philip J. Chowienczyk
Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism
Edzard Schwedhelm, Renke Maas, Ralf Freese, Donald Jung, Zoltan Lukacs, Alen Jambrecina, William Spickler, Friedrich Schulze, Rainer H. Böger
Lipoic acid supplementation and endothelial function
J-C Tardif, E Rhéaume
Effects of pre- vs. intra-dialysis folic acid on arterial wave reflections and endothelial function in patients with end-stage renal disease
Yuka Tochihara, Malcolm J. Whiting, Jeffrey A. Barbara, Arduino A. Mangoni
Transport of interleukin-1 across cerebromicrovascular endothelial cells
RA Skinner, RM Gibson, NJ Rothwell, E Pinteaux, JI Penny
Non-invasive measurement of the haemodynamic effects of inhaled salbutamol, intravenous L-arginine and sublingual nitroglycerin
Anna Tahvanainen, Miia Leskinen, Jenni Koskela, Erkki Ilveskoski, Juha Alanko, Mika Kähönen, Tiit Kööbi, Lauri Lehtimäki, Eeva Moilanen, Jukka Mustonen, Ilkka Pörsti
Endothelial Pathophysiology
Celecoxib modulates adhesion of HT29 colon cancer cells to vascular endothelial cells by inhibiting ICAM-1 and VCAM-1 expression
C Dianzani, L Brucato, M Gallicchio, A C Rosa, M Collino, R Fantozzi
Endothelium removal augments endothelium-independent vasodilatation in rat mesenteric vascular bed
Y Iwatani, K Kosugi, S Isobe-Oku, S Atagi, Y Kitamura, H Kawasaki
Effects of α-lipoic acid on endothelial function in aged diabetic and high-fat fed rats
C M Sena, E Nunes, T Louro, T Proença, R Fernandes, M R Boarder, R M Seiça
Raloxifene protects endothelial cell function against oxidative stress
C M Wong, L M Yung, F P Leung, S-Y Tsang, C L Au, Z-Y Chen, X Yao, C H K Cheng, C-W Lau, M Gollasch, Y Huang
Aldosterone induces endothelial dysfunction in resistance arteries from normotensive and hypertensive rats by increasing thromboxane A2 and prostacyclin
F E Xavier, R Aras-López, I Arroyo-Villa, L del Campo, M Salaices, L V Rossoni, M Ferrer, G Balfagón
Increased endothelin-1 reactivity and endothelial dysfunction in carotid arteries from rats with hyperhomocysteinemia
CR de Andrade, PF Leite, AC Montezano, DA Casolari, A Yogi, RC Tostes, R Haddad, MN Eberlin, FRM Laurindo, HP de Souza, FMA Corrêa, AM de Oliveira
Inflammation
Ethyl pyruvate modulates acute inflammatory reactions in human endothelial cells in relation to the NF-κB pathway
A-S Johansson, K Johansson-Haque, S Okret, J Palmblad
Secretory PLA2 inhibitor indoxam suppresses LDL modification and associated inflammatory responses in TNF α-stimulated human endothelial cells
K Sonoki, M Iwase, N Sasaki, S Ohdo, S Higuchi, Y Takata, M Iida
Signalling / Drug targets
Contribution of the M3 muscarinic receptors to the vasodilator response to acetylcholine in the human forearm vascular bed
Teresa M. Attinà, James J. Oliver, Lorenzo S. Malatino, David J. Webb
Short-term or long-term treatments with a phosphodiesterase-4 (PDE4) inhibitor result in opposing agonist-induced Ca2+ responses in endothelial cells
M Campos-Toimil, T Keravis, F Orallo, K Takeda, C Lugnier
Oxytocin stimulates migration and invasion in human endothelial cells
M G Cattaneo, B Chini, L M Vicentini
Endothelial α1-adrenoceptors regulate neo-angiogenesis
M Ciccarelli, G Santulli, A Campanile, G Galasso, P Cervèro, G G Altobelli, V Cimini, L Pastore, F Piscione, B Trimarco, G Iaccarino
Activation of ETB receptors regulates the abundance of ET-1 mRNA in vascular endothelial cells
N Farhat, C C Matouk, A M Mamarbachi, P A Marsden, B G Allen, E Thorin
Smooth muscle α1D-adrenoceptors mediate phenylephrine-induced vasoconstriction and increases in endothelial cell Ca2+ in hamster cremaster arterioles
W F Jackson, E M Boerman, E J Lange, S S Lundback, K D Cohen
Virodhamine relaxes the human pulmonary artery through the endothelial cannabinoid receptor and indirectly through a COX product
H Kozłowska, M Baranowska, E Schlicker, M Kozłowski, J Laudañski, B Malinowska
H2S-donating sildenafil (ACS6) inhibits superoxide formation and gp91phox expression in arterial endothelial cells: role of protein kinases A and G
S Muzaffar, J Y Jeremy, A Sparatore, P Del Soldato, G D Angelini, N Shukla
Oleanolic acid induces relaxation and calcium-independent release of endothelium-derived nitric oxide
R Rodriguez-Rodriguez, E Stankevicius, M D Herrera, L Østergaard, M R Andersen, V Ruiz-Gutierrez, U Simonsen
Effects of chronic in vivo administration of nitroglycerine on ACh-induced endothelium-dependent relaxation in rabbit cerebral arteries
Y Watanabe, N Kusama, T Itoh
Resveratrol reduces endothelial progenitor cells senescence through augmentation of telomerase activity by Akt-dependent mechanisms
L Xia, X X Wang, X S Hu, X G Guo, Y P Shang, H J Chen, C L Zeng, F R Zhang, J Z Chen
Kaempferol stimulates large conductance Ca2+-activated K+ (BKCa) channels in human umbilical vein endothelial cells via a cAMP/PKA-dependent pathway
Y C Xu, G P H Leung, P Y D Wong, P M Vanhoutte, R Y K Man
Levosimendan induces NO production through p38 MAPK, ERK and Akt in porcine coronary endothelial cells: role for mitochondrial KATP channel
E Grossini, C Molinari, PP Caimmi, F Uberti, G Vacca
Myoendothelial coupling in the mesenteric arterial bed; segmental differences and interplay between nitric oxide and endothelin-1
RHP Hilgers, JGR De Mey
Protopanaxadiol and protopanaxatriol bind to glucocorticoid and oestrogen receptors in endothelial cells
Kar Wah Leung, Fung Ping Leung, Nai Ki Mak, Joyce Tombran-Tink, Yu Huang, Ricky NS Wong
Mechanisms of U46619-induced contraction of rat pulmonary arteries in the presence and absence of the endothelium
C McKenzie, A MacDonald, AM Shaw
Amiloride derivatives induce apoptosis by depleting ER Ca2+ stores in vascular endothelial cells
KS Park, D Poburko, CB Wollheim, N Demaurex
Cancer: Virtual Issue
This virtual issue brings together a collection of recent cancer papers and reviews that have been well-read and cited, demonstrating the range of our coverage: from characterisation of new drug targets to investigation of novel therapeutics and mechanistic studies of known drugs, using a wide range of in vitro and in vivo approaches.
Heparanase: a target for drug discovery in cancer and inflammation
E A McKenzie
A cellular and molecular investigation of the action of PMX464, a putative thioredoxin inhibitor, in normal and colorectal cancer cell lines
A Mukherjee, K Huber, H Evans, N Lakhani, S Martin
Telomerase and its potential for therapeutic intervention
P Phatak, A M Burger
Biomarker method validation in anticancer drug development
J Cummings, T H Ward, A Greystoke, M Ranson, C Dive
Inhibitors of histone deacetylase (HDAC) restore the p53 pathway in neuroblastoma cells
F Condorelli, I Gnemmi, A Vallario, A A Genazzani, P L Canonico
Celecoxib decreases expression of the adhesion molecules ICAM-1 and VCAM-1 in a colon cancer cell line (HT29)
M Gallicchio, A C Rosa, C Dianzani, L Brucato, E Benetti, M Collino, R Fantozzi
5-Aza-2'-deoxycytidine suppresses human renal carcinoma cell growth in a xenograft model via up-regulation of the connexin 32 gene
H Hagiwara, H Sato, Y Ohde, Y Takano, T Seki, T Ariga, N Hokaiwado, M Asamoto, T Shirai, Y Nagashima, T Yano
Tumour endoproteases: the cutting edge of cancer drug delivery?
J M Atkinson, C S Siller, J H Gill
Photodynamic activity of BAM-SiPc, an unsymmetrical bisamino silicon(IV) phthalocyanine, in tumour-bearing nude mice
S C H Leung, P-C Lo, D K P Ng, W-K Liu, K-P Fung, W-P Fong
Discovery and biological characterization of a novel series of androgen receptor modulators
C Zhou, G Wu, Y Feng, Q Li, H Su, D E Mais, Y Zhu, N Li, Y Deng, D Yang, M-W Wang
Cancer and the blood-brain barrier: 'Trojan horses' for courses? M Mazza, I F Uchegbu, A G Schätzlein
Alpha-2 adrenoceptor action on cell proliferation and mammary tumour growth in mice
A Bruzzone, C Pérez Piñero, L F Castillo, M G Sarappa, P Rojas, C Lanari, I A Lüthy
Journal Menu
- Information for Authors
- Information for Referees
- Information for Librarians
- Information for Advertisers
- Information for Members
- Journal Issues
- Accepted Articles
- Early View
- Cover Archive
- Themed Issues
Guide to Receptors and Channels - Virtual Issues
- Aims & Scope
- Editorial Board
- Get News RSS Feed
- Sign up for E-Alerts
- Submit Article
- Recommend to Library
- Contact Us
.jpg)


